Inhibiting the dimeric restriction endonuclease EcoRI using interfacial helical peptides
1Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.
Chemistry & Biology
|July 8, 1998
Summary
Researchers designed helical peptides to inhibit the EcoRI enzyme by disrupting its dimer formation. A specific alpha 4 peptide effectively blocked EcoRI dimerization and activity, showing potential for enzyme inhibition strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzyme Inhibition
Background:
- Many enzymes, including type II restriction endonucleases like EcoRI, require a dimeric form for activity.
- Disrupting multimeric enzyme interactions is a viable strategy for enzyme inhibition.
- The EcoRI enzyme's dimeric interface is characterized by a four-helix bundle.
Purpose of the Study:
- To design and synthesize helical peptides targeting the EcoRI enzyme's interfacial region.
- To inhibit EcoRI dimerization and consequently its endonuclease activity.
- To investigate the structure-activity relationship of these peptide inhibitors.
Main Methods:
- Design of synthetic helical peptides based on EcoRI's interfacial region.
- Enzyme inhibition assays to determine efficacy (IC50 values).
- Circular dichroism and size-exclusion chromatography to assess protein structure and complex formation.
Main Results:
- Two peptides were synthesized; the alpha 4 peptide demonstrated higher helical content (29%) and better inhibitory efficacy (IC50=27 μM) compared to a variant (alpha 4(Leu)).
- Size-exclusion chromatography confirmed disruption of EcoRI dimerization by the alpha 4 peptide.
- Circular dichroism showed EcoRI maintained its folded structure upon peptide binding, and inhibition was specific to EcoRI.
Conclusions:
- Successfully developed interfacial peptide inhibitors for dimeric EcoRI, effectively inhibiting both dimerization and endonuclease activity.
- Peptides with higher helical propensity showed enhanced inhibitory effects, likely due to optimized interaction with EcoRI's helical interface.
- The study confirms the specificity of the endonuclease-peptide interaction and suggests broader applicability for enzyme inhibition strategies.
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:11Restriction Enzymes
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...